reglan and tardive dyskinesia

FDA notified healthcare professionals that a boxed warning had to be added to drug labels about the risk of long-term or high-dose use of metoclopramide (reglan) and the possibility of tardive dyskinesia.    There is no reversal of tardive dyskinesia and no treatment available. What is tardive dyskinesia?


circumcision and health

google jumps in on flu trends